Catalyst Wire Dossier Catalyst Wire Dossier

0.1% FK506 eye drops

tacrolimus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 0.1% FK506 eye drops, covering 2022-03-24 to 2022-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment [Phase 4]

See pricing